Skip to main content
. 2012 Sep 13;9:43. doi: 10.1186/1550-2783-9-43

Table 13.

Whole blood markers

Marker
N
Group
Day
 
p-level
      0 7 28    
WBC (x103/ul)
9
KA-L
5.73 ± 0.6
6.13 ± 0.5
6.17 ± 1.5
Group
0.95
 
12
KA-H
5.83 ± 1.1
5.76 ± 0.9
6.36 ± 1.1
Time
0.16
 
12
CrM
5.97 ± 1.2
5.73 ± 1.0
5.98 ± 1.2
G x T
0.45
RBC (x106/ul)
9
KA-L
5.44 ± 0.4
5.38 ± 0.5
5.44 ± 0.3
Group
0.28
 
12
KA-H
5.10 ± 0.4
5.18 ± 0.3
5.23 ± 0.3
Time
0.91
 
12
CrM
5.42 ± 0.5
5.41 ± 0.5
5.35 ± 0.7
G x T
0.64
Hematocrit (%)
9
KA-L
48.4 ± 3.4
47.9 ± 4.3
48.1 ± 2.9
Group
0.17
 
12
KA-H
46.5 ± 3.2
47.0 ± 2.8
47.4 ± 1.8
Time
0.96
 
12
CrM
45.9 ± 2.3
46.1 ± 2.5
45.2 ± 5.4
G x T
0.65
Hemoglobin (g/dl)
9
KA-L
16.0 ± 1.6
16.0 ± 1.6
16.0 ± 1.2
Group
0.21
 
12
KA-H
15.2 ± 1.2
15.7 ± 1.0
15.6 ± 0.7
Time
0.60
 
12
CrM
15.1 ± 0.9
15.2 ± 1.1
14.9 ± 2.0
G x T
0.62
MCV (fL)
9
KA-L
89.0 ± 2.8
88.9 ± 2.9
88.3 ± 2.8
Group
0.10
 
12
KA-H
91.1 ± 3.5
90.8 ± 3.1
90.7 ± 3.6
Time
0.03
 
12
CrM
85.4 ± 9.2
85.7 ± 9.5
85.0 ± 9.1
G x T
0.56
MCH (pg/cell)
9
KA-L
29.4 ± 1.5
29.6 ± 1.2
29.3 ± 1.2
Group
0.34
 
12
KA-H
29.8 ± 1.6
30.2 ± 1.5
28.4 ± 4.9
Time
0.20
 
12
CrM
28.1 ± 3.5
28.3 ± 3.7
27.9 ± 3.3
G x T
0.44
MCHC
(g/dl)
9
KA-L
33.0 ± 1.3
33.3 ± 0.9
33.2 ± 0.9
Group
0.73
 
12
KA-H
32.8 ± 0.9
33.3 ± 0.8
32.9 ± 0.6
Time
0.22
 
12
CrM
32.9 ± 1.1
32.9 ± 1.3
32.9 ± 0.8
G x T
0.68
RBCDW (%)
9
KA-L
13.0 ± 0.5
13.0 ± 0.9
12.9 ± 0.7
Group
0.34
 
12
KA-H
13.8 ± 1.1
13.7 ± 1.0
13.5 ± 1.5
Time
0.41
 
12
CrM
13.7 ± 1.4
13.7 ± 1.7
13.6 ± 1.6
G x T
0.92
Platelet Count (x103/ul)
9
KA-L
266 ± 45
266 ± 52
280 ± 45
Group
0.12
 
12
KA-H
253 ± 54
248 ± 62
269 ± 65
Time
0.32
  12 CrM 222 ± 69 222 ± 74 216 ± 65 G x T 0.48

Values are means ± standard deviations. White and red cell whole blood markers were analyzed by MANOVA with repeated measures. Greenhouse-Geisser time and group x time (G x T) interaction p-levels are reported with univariate group p-levels.

HHS Vulnerability Disclosure